DUBLIN–(BUSINESS WIRE)–The “North America Virtual Clinical Trials Market By Study Type, By Indication, By Country, Industry Analysis and Forecast, 2020 – 2026” report has been added to ResearchAndMarkets.com’s offering.
The North America Virtual Clinical Trials Market is expected to witness market growth of 4.8% CAGR during the forecast period (2020-2026).
The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.
The patient-centric approach is followed by a virtual trial, permitting for a better traditional trail experience for the participants together with improved data collection, expanded diversity of patients, and time savings from the view of the trial duration. The virtual trial takes full benefit of the majority of digital instruments available and is defined by no physical visits to a trail site.
There is no dearth of terms of labels that are being used to explain the notion of virtual trails. From virtual to mobile-enabled, to remote, to advance, to modern era clinical trials, to adaptable, to digitally-enabled, to software-enabled, to site-less, to direct-to-patient, and the list goes on.
The outbreak of the Covid-19 pandemic is compelling the clinical trial industry to change the process of performing ongoing or upcoming trials. The year 2020 has changed the lives of people upside down. The lockdown guidelines are being observed across the world and the clinical trial industry is no exception to this.
Based on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. Based on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.2 Key Factors Impacting the Market
Chapter 3. Competition Analysis – Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. North America Virtual Clinical Trials Market by Study Type
4.1 North America Interventional Market by Country
4.2 North America Observational Market by Country
4.3 North America Expanded Access Market by Country
Chapter 5. North America Virtual Clinical Trials Market by Indication
5.1 North America Oncology Market by Country
5.2 North America Cardiovascular Market by Country
5.3 North America Immunology Market by Country
5.4 North America Gastrointestinal Market by Country
5.5 North America Respiratory Market by Country
5.6 North America Endocrinology Market by Country
5.7 North America Ophthalmology Market by Country
5.8 North America Other Indications Market by Country
Chapter 6. North America Virtual Clinical Trials Market by Country
6.1 US Virtual Clinical Trials Market
6.1.1 US Virtual Clinical Trials Market by Study Type
6.1.2 US Virtual Clinical Trials Market by Indication
6.2 Canada Virtual Clinical Trials Market
6.2.1 Canada Virtual Clinical Trials Market by Study Type
6.2.2 Canada Virtual Clinical Trials Market by Indication
6.3 Mexico Virtual Clinical Trials Market
6.3.1 Mexico Virtual Clinical Trials Market by Study Type
6.3.2 Mexico Virtual Clinical Trials Market by Indication
6.4 Rest of North America Virtual Clinical Trials Market
6.4.1 Rest of North America Virtual Clinical Trials Market by Study Type
6.4.2 Rest of North America Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
- IQVIA Holdings, Inc.
- ICON PLC
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Oracle Corporation
- Parexel International Corporation (Pamplona Capital Management)
- PRA Health Sciences, Inc. (KKR & Co., Inc.)
- Medpace Holdings, Inc.
- Medable, Inc.
- Clinical Ink, Inc. (G.I. Partners)
For more information about this report visit https://www.researchandmarkets.com/r/hs4yjz
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900